The expanding demand for specific immunological investigation and therapeutic design has spurred significant progress in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using diverse expression platforms, including microbial hosts, animal cell lines, and baculoviru